Michael Perloff

3.7k total citations
73 papers, 2.4k citations indexed

About

Michael Perloff is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Pathology and Forensic Medicine. According to data from OpenAlex, Michael Perloff has authored 73 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 14 papers in Pediatrics, Perinatology and Child Health and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Michael Perloff's work include Drug Transport and Resistance Mechanisms (14 papers), Pharmacological Effects and Toxicity Studies (14 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Michael Perloff is often cited by papers focused on Drug Transport and Resistance Mechanisms (14 papers), Pharmacological Effects and Toxicity Studies (14 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Michael Perloff collaborates with scholars based in United States, Puerto Rico and Italy. Michael Perloff's co-authors include Nuel Belnap, David J. Greenblatt, Lisa L. von Moltke, Ming Xu, Elke Störmer, Richard I. Shader, James E. Marchand, J F Holland, Tsutomu Kotegawa and James F. Holland and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Michael Perloff

69 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Perloff United States 28 937 393 387 371 330 73 2.4k
Dana C. Crawford United States 35 258 0.3× 741 1.9× 390 1.0× 335 0.9× 268 0.8× 151 5.9k
Lang Li United States 39 1.4k 1.5× 642 1.6× 402 1.0× 119 0.3× 622 1.9× 158 5.1k
Russell A. Wilke United States 34 484 0.5× 1.4k 3.6× 523 1.4× 189 0.5× 282 0.9× 93 4.5k
Lara M. Mangravite United States 32 586 0.6× 256 0.7× 264 0.7× 46 0.1× 273 0.8× 58 2.8k
Monette Cotreau United States 19 359 0.4× 312 0.8× 130 0.3× 25 0.1× 162 0.5× 52 1.8k
Lisa Bastarache United States 20 728 0.8× 60 0.2× 85 0.2× 218 0.6× 105 0.3× 60 3.0k
Sumei Wang China 34 627 0.7× 105 0.3× 226 0.6× 191 0.5× 729 2.2× 159 4.3k
Gregory D. Jenkins United States 37 802 0.9× 356 0.9× 172 0.4× 22 0.1× 543 1.6× 127 4.6k
George P. Patrinos Greece 35 370 0.4× 930 2.4× 829 2.1× 65 0.2× 498 1.5× 303 6.6k
Melissa Basford United States 19 110 0.1× 285 0.7× 183 0.5× 537 1.4× 93 0.3× 36 2.6k

Countries citing papers authored by Michael Perloff

Since Specialization
Citations

This map shows the geographic impact of Michael Perloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Perloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Perloff more than expected).

Fields of papers citing papers by Michael Perloff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Perloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Perloff. The network helps show where Michael Perloff may publish in the future.

Co-authorship network of co-authors of Michael Perloff

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Perloff. A scholar is included among the top collaborators of Michael Perloff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Perloff. Michael Perloff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perloff, Michael, et al.. (2022). Pharmacotherapy for Spine-Related Pain in Older Adults. Drugs & Aging. 39(7). 523–550. 25 indexed citations
2.
Perloff, Michael, et al.. (2019). Cerebrospinal Fluid Removal for Idiopathic Intracranial Hypertension: Less Cerebrospinal Fluid Is Best. Journal of Neuro-Ophthalmology. 39(3). 330–332. 5 indexed citations
3.
Perloff, Michael, et al.. (2017). Triptans and migraine: advances in use, administration, formulation, and development. Expert Opinion on Pharmacotherapy. 18(4). 387–397. 18 indexed citations
4.
Perloff, Michael. (2016). STIT AND THE IMPERATIVE. American Philosophical Quarterly. 32(1). 71–81.
5.
Perloff, Michael, et al.. (2016). Physical Medicine and Rehabilitation. American Journal of Physical Medicine & Rehabilitation. 96(2). 131–132. 1 indexed citations
6.
Perloff, Michael, et al.. (2015). No Pain, No Pigment. American Journal of Physical Medicine & Rehabilitation. 95(1). e9–e9. 2 indexed citations
7.
Butler, Paul, et al.. (2013). Beyond Neuropathic Pain. Clinical Journal of Pain. 30(7). 613–629. 39 indexed citations
8.
Perloff, Michael & Nuel Belnap. (2011). Future Contingents and the Battle Tomorrow. ˜The œreview of metaphysics. 64(3). 581. 5 indexed citations
9.
Perloff, Michael, et al.. (2011). Suspecting Optic Neuritis, Diagnosing Bartonella Cat Scratch Disease. Archives of Neurology. 68(1). 122–6. 7 indexed citations
10.
Perloff, Michael, et al.. (2011). Anorgasmia with Gabapentin May Be Common in Older Patients. ˜The œAmerican journal of geriatric pharmacotherapy. 9(3). 199–203. 16 indexed citations
11.
Moltke, Lisa L. von, Brian Granda, Jeffrey M. Grassi, et al.. (2004). INTERACTION OF TRIAZOLAM AND KETOCONAZOLE IN P-GLYCOPROTEIN-DEFICIENT MICE. Drug Metabolism and Disposition. 32(8). 800–804. 30 indexed citations
12.
Perloff, Michael, Lisa L. von Moltke, & David J. Greenblatt. (2002). Fexofenadine Transport in Caco‐2 Cells: Inhibition with Verapamil and Ritonavir. The Journal of Clinical Pharmacology. 42(11). 1269–1274. 75 indexed citations
13.
Kotegawa, Tsutomu, Bart Laurijssens, Lisa L. von Moltke, et al.. (2002). In Vitro, Pharmacokinetic, and Pharmacodynamic Interactions of Ketoconazole and Midazolam in the Rat. Journal of Pharmacology and Experimental Therapeutics. 302(3). 1228–1237. 88 indexed citations
14.
Perloff, Michael, Lisa L. von Moltke, James E. Marchand, & David J. Greenblatt. (2001). Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell line. Journal of Pharmaceutical Sciences. 90(11). 1829–1837. 117 indexed citations
15.
Perloff, Michael, Lisa L. von Moltke, Elke Störmer, Richard I. Shader, & David J. Greenblatt. (2001). Saint John's wort: An in vitro analysis of P‐glycoprotein induction due to extended exposure. British Journal of Pharmacology. 134(8). 1601–1608. 136 indexed citations
16.
Störmer, Elke, Lisa L. von Moltke, Michael Perloff, & David J. Greenblatt. (2001). P‐glycoprotein Interactions of Nefazodone and Trazodone in Cell Culture. The Journal of Clinical Pharmacology. 41(7). 708–714. 28 indexed citations
17.
Beinfeld, Margery C., Michael Perloff, & Karthik Venkatakrishnan. (1998). Identification of glycine-extended CCK peptides in endocrine cells and modulation of CCK amide and CCK gly content and secretion from endocrine tumor cells by an inhibitor of amidation. Peptides. 19(8). 1393–1398. 8 indexed citations
18.
Pazur, John H., et al.. (1996). Comparison of the properties of concanavalin A and anti-α-d-glucose antibodies. Journal of Protein Chemistry. 15(4). 329–335. 1 indexed citations
19.
DeCensi, Andrea, Silvia Bruno, Massimo Costantini, et al.. (1994). Phase IIa Study of Fenretinide in Superficial Bladder Cancer, Using DNA Flow Cytometry as an Intermediate End Point. JNCI Journal of the National Cancer Institute. 86(2). 138–140. 52 indexed citations
20.
Perloff, Michael & J F Holland. (1977). Surgical Adjuvant Chemotherapy. Annual Review of Medicine. 28(1). 475–488. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dana C. Crawford Breakdown of academic impact, for papers by Lang Li Breakdown of academic impact, for papers by Russell A. Wilke Breakdown of academic impact, for papers by Lara M. Mangravite Breakdown of academic impact, for papers by Monette Cotreau Breakdown of academic impact, for papers by Lisa Bastarache Breakdown of academic impact, for papers by Sumei Wang Breakdown of academic impact, for papers by Gregory D. Jenkins Breakdown of academic impact, for papers by George P. Patrinos Breakdown of academic impact, for papers by Melissa Basford
Rankless by CCL
2026